← Browse by Condition
Medical Condition

bacterial infections

Total Trials
3
Recruiting Now
3
Trial Phases
Phase 3

ClinicalMetric tracks all active clinical trials for bacterial infections sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — bacterial infections Clinical Trials

How many clinical trials are currently recruiting for bacterial infections?
ClinicalMetric currently tracks 3 actively recruiting clinical trials for bacterial infections, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 3. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for bacterial infections?
bacterial infections research spans Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a bacterial infections clinical trial?
Eligibility criteria for bacterial infections trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 3
1
Top Sponsors
Hospital Israelita Albert Einstein 1 trial
GramEye 1 trial
CanSino Biologics Inc. 1 trial

Recruiting Clinical Trials

NCT07062445
Recruiting

Prospective Clinical Registry of Acute Treatment and Long-term Assessment of Children Meningitis

Enrollment
600 pts
Location
Brazil
Sponsor
Hospital Israelita Albert Eins...
View Trial →
NCT06519032
Recruiting

Development and Evaluation of Rapid Bacterial Species Identification for Acid-Fast Bacilli Smear Using Image Analysis AI

Enrollment
10,000 pts
Location
Japan
Sponsor
GramEye
View Trial →
NCT07017777 Phase 3
Recruiting

A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)

Enrollment
600 pts
Location
Thailand
Sponsor
CanSino Biologics Inc.
View Trial →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology